Publications by authors named "Ruijin Ji"

Claim this Profile
E
Emerging trends in gene and cell therapy: CRISPR in DNA editing and beyond.
Ruijin Ji, Qiubing Chen, Ying Zhang

Cell Rep Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors.
Min Duan, Pan Gao, Yi-Zhou Zhang, Yu-Long Hu, Lei Zhou, Rui-Jin Ji

Nat Chem Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid generation of long, chemically modified pegRNAs for prime editing.
Xinlin Lei, Anhui Huang, Didi Chen, Xuebin Wang, Ruijin Ji, Jinlin Wang

Nat Biotechnol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision epitope editing: A path to advanced immunotherapies.
Rui-Jin Ji, Mu-Yao Wang, Ying Zhang

Cell Insight· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia.
Rui-Jin Ji, Guo-Hua Cao, Wei-Qiang Zhao, Mu-Yao Wang, Pan Gao

Cell Stem Cell· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and sensitive CRISPR detection by minimized interference of target amplification.
Xiaohan Tong, Kun Zhang, Yang Han, Tianle Li, Min Duan, Ruijin Ji

Nat Chem Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs.
Wenyan Han, Hou-Yuan Qiu, Shangwu Sun, Zhi-Can Fu, Guo-Quan Wang, Lijie Wang, Jia Wei, Rui-Jin Ji, Jing Wu, Jia Chen

Cell Stem Cell· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current advances of CRISPR-Cas technology in cell therapy.
Hou-Yuan Qiu, Rui-Jin Ji, Ying Zhang

Cell Insight· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis